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A FASEB Summer Research
Conference entitled ‘Arf and Rab
family G proteins’ was held in July
2013 at Snowmass Village, Snowmass,
Colorado. Arfs and Rabs are two
families of GTPases that control
membrane trafficking in eukaryotic
cells, and increasing evidence indicates
that their functions are tightly
coordinated. Because many workers in
this field have focused on only one
family, this meeting was designed to
integrate our understanding of the two
families. The conference was organized
by Elizabeth Sztul (University of
Alabama, Birmingham, USA) and Jim
Casanova (University of Virginia,
Charlottesville, USA), and provided an
opportunity for ,90 scientists to
communicate their work and discuss
future directions for the field. The
talks highlighted the structural,
functional and regulatory properties of
Arf and Rab GTPases and the need to
develop coordinated approaches to
investigate them. Here, we present the
major themes that emerged from the
meeting.
Coincidence detection provides
spatial and temporal regulation to
GTPase activity
The activation and inactivation of
GTPases requires guanine-nucleotide-
exchange factors (GEFs) and GTPase-
activating proteins (GAPs), respectively.
Accumulating evidence indicates that most,
if not all, GEFs and GAPs are autoinhibited
in the cytosol and are activated upon
recruitment to a membrane. One of the
best-understood autoinhibitory mechanisms
is the masking of the catalytic domain by an
adjacent pleckstrin homology (PH) domain.
Interaction of the PH domain with
membrane components (phospholipids and/
or proteins) relieves this inhibition, resulting
in local site-specific activation. David
Lambright (University of Massachusetts,
Worcester, MA, USA) described the
activation of the cytohesin/ARNO family
of Arf GEFs through simultaneous
recognition of two membrane components:
an activated Arf and a phosphoinositide.
Structural studies showed that simultaneous
binding causes a major conformational shift
that displaces the PH domain and frees the
catalytic Sec7 domain for interaction with its
substrate, Arf-GDP. His data support a
positive-feedback model in which the
product of cytohesin activation (Arf-GTP)
further stimulates cytohesin activity.
In contrast, structural data presented
by Jacqueline Cherfils (CNRS, Gif-sur-
Yvette, France) showed that the PH
domain of a different Arf GEF, BRAG2,
is not autoinhibitory; instead it is part of
the catalytic mechanism, potentiating
nucleotide exchange in the presence of
negatively charged lipids. Thus, although
they act through distinct mechanisms, the
PH domains of cytohesins and BRAG2
control Arf activation through recognition
of specific membrane microenvironments.
Many Arf GAPs are also regulated by
their PH domains, and Paul Randazzo
(NIH, Bethesda, USA) presented a new
regulatory mechanism for ASAP1. In this
case, autoinhibition is mediated by an N-
terminal BAR domain, and is relieved
upon binding to an appropriate
membrane. ASAP1 also contains a PH
domain, and analogous to the role of the
PH domain in the GEF BRAG2 (see
above), binding of PtIns(4,5)P2 results in
a conformational change that allows the
PH domain to present the substrate
(ARF1-GTP) to the ASAP1 GAP domain.
A different form of autoinhibition is
found in a large family of Rab GEFs, the
DENN domain family, as presented by
Peter McPherson (McGill University,
Montreal, Canada). Here, the
autoinhibition of connecdenn/DENN1A
(a GEF for Rab35) is relieved through the
phosphorylation of serine residues within
its C-terminal region, indicating that
kinases can also function as components
of the coincidence detection network.
The large, Golgi-associated Arf GEFs
of the GBF1/BIG1/BIG2 subfamily do
not contain PH domains, and are
regulated through other mechanisms.
Paul Melancon (University of Alberta,
Edmonton, Canada) showed that
recruitment of mammalian GBF1 to
membranes is stimulated by inactive
GDP-bound Arf1, but the underlying
mechanism remains to be determined.
Another layer of regulation was discussed
by Rick Kahn (Emory University,
Atlanta, USA), who proposed that the
recruitment and activation of large Arf
GEFs is linked to the presence of cargo,
with other membrane components (e.g.
phosphoinositides) providing additional
specificity. An important concept that
emerged from his talk is that different
cargoes recruit different modules of
GEFs, Arfs and coat components,
implying that cargo imparts specificity
to GEF output.
A key aim in the field is to identify all
the components of the coincidence
detection mechanisms through which
GEFs and GAPs are positioned and
activated at specific membrane sites.
Apart from the obvious factors, such as
phosphoinositides and cargo, additional
binding partners of GEFs and GAPs
(scaffolds, other GTPases and kinases)
are likely to participate in coincidence
detection and should be investigated in
depth.
Many Arfs and Rabs exist in
regulatory GTPase cascades
Directionality of membrane traffic can be
achieved by ordering of regulatory events
such that events that occur later in a
transport pathway cannot occur without
the prior early events that set them up.
The Rab cascades that regulate the secretory
pathway were discussed in several talks.
Nava Segev (University of Illinois at
Chicago, USA) discussed how Golgi entry
and exit is coordinated by Ypts (yeast Rabs)
and their GEFs. The idea is that Ypt1, which
is involved in ER-to-Golgi trafficking, is
activated by themultisubunit GEF TRAPPI;
Ypt1 then recruits TRAPPII, a GEF for the
late-Golgi Rabs Ypt31 and Ypt32. Such a
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cascade ensures vectorial traffic of cargo
from the ER through the Golgi to the plasma
membrane. Alternatively, TRAPPI can also
convert into TRAPPIII to stimulate the
function of Ypt1 in the autophagic pathway,
thereby coordinating the function of a single
Rab in shuttling cargo to two different
destinations. Peter Novick (University of
California San Diego, San Diego, USA)
described a Rab cascade that acts in the
formation of yeast secretory vesicles, in
which the Golgi-associated Rab Ypt32
binds and recruits Sec2 (a GEF for the
vesicle-associated Rab Sec4) to nascent
transport vesicles. Sec2 also binds Sec15p
(a component of the exocyst tethering
complex) and PtdIns(4)P. Importantly,
Sec2 binding to Ypt32 and Sec15
is inversely regulated by PtdIns(4)P;
as PtdIns(4)P levels decrease, Sec2
dissociates from Ypt32 and its binding
to Sec15 is enhanced. This ‘maturation
cascade’ results in secretory vesicles that are
primed for vesicle fusion at the plasma
membrane. A third example of a Rab
cascade was provided by Suzanne Pfeffer
(Stanford University, Stanford, USA), who
described cross-talk between Golgi Rabs
Rab33B and Rab6. She showed that the
medial Golgi-localized Rab33B recruits a
heterodimeric GEF comprised of Ric1 and
Rgp1, that subsequently activates the trans-
Golgi network (TGN)-localized Rab6.
Finally, Anne Spang (University of Basel,
Basel, Switzerland) discussed a Rab
cascade in the endocytic pathway, in
which the transition from early endosomes
(EEs) to late endosomes (LEs) is facilitated
by the loss of Rab5 and acquisition of Rab7.
She showed that SAND-1/Mon1 plays a key
role in this process by displacing rabex5 (a
GEF for Rab5) from EEs, thus causing the
dissociation of Rab5 from membranes, and
simultaneously acting as a GEF for Rab7,
promoting maturation to LEs. Thus,
cascades involving Rabs, their GAPs and
GEFs promote maturation of transport
intermediates within the secretory and
endocytic pathways.
Rabs also participate in mixed cascades
with Arfs to regulate each other’s activity,
as showcased by Peter McPherson (McGill
University, Montreal, Canada) who
described a cascade involving Rab35 and
Arf6. In this pathway, Rab35 recruits the
Arf6 GAP ACAP2 to regulate Arf6
activation. The balance between Rab35
and Arf6 activities affects cell migration
by modulating the recycling of cadherins
and integrins, and reduced Rab35 levels
that lead to enhanced Arf6 activity
correlate with enhanced metastatic
potential of cancer cells. Julie Donaldson
(NIH, Bethesda, USA) focused on the
Rab35–Arf6 cascade in the context
of clathrin-independent endosomal
trafficking. She presented evidence that
blockade of clathrin-mediated endocytosis
caused retention of Rab35 at the plasma
membrane. Although this led to a slight
elevation in Arf6-GTP, it actually
increased degradation (rather than
recycling) of clathrin-independent cargo.
The molecular basis for this result remains
to be determined. Another example of a
mixed Arf–Rab regulatory cascade in
retinal photoreceptor cells was presented
by Duska Deretic (University of New
Mexico, Albuquerque, NM). In these
cells, activation of Arf4 at the TGN
triggers the recruitment of the Arf GAP
ASAP1, which in turn binds to Rab11. The
resulting complex serves as a scaffold for
the assembly of a Rab11–Rabin8–Rab8
complex that is necessary for delivery of
rhodopsin to the light-sensing organelles
of these cells.
Arf GEFs also participate in signaling
cascades, as illustrated in the talk by
Elizabeth Sztul (UAB, Birmingham, AL),
who presented insights into the GBF1–
Arf–BIG1/BIG2–Arf cascade at the TGN.
At the top of the cascade, GBF1 activates
its substrates (Arf1, Arf4 and Arf5),
which then bind the N-terminal domains
of BIG1 and BIG2 and recruit them to
membranes to facilitate the activation of
their substrates (Arf1 and Arf3). GBF1
mediates the Arf-dependent recruitment
of COPI at the ER–Golgi interface,
whereas BIG1 and BIG2 recruit Arf-
dependent TGN coats. This suggests that
GBF1, by affecting the activity of BIG1
and BIG2, also (indirectly) regulates the
recruitment of TGN coats and thus might
coordinate trafficking of cargo through
the entire secretory pathway.
The identification of BIG1 and BIG2
as effectors of Arf4 and Arf5 raises
the key question of what constitutes
an Arf-effector interaction domain?
Julie Menetrey (CNRS, Gif-sur-Yvette,
France) showed that although effectors
bind to the same switch regions on active
Arfs, the Arf-binding domains in different
effectors vary greatly. Indeed, such
domains can be either b-sheets (as in
the Arf6 effector MKLP1), a-helices (as
in GGA proteins) or contain mixed folds
(as in ARHGAP21). Her findings were
greeted with uniform disappointment
because they preclude the prediction of
possible effector domains based on
structural information alone.
Taken together, an extensive functional
crosstalk among Arfs and Rabs, as well as
their regulators and effectors highlights
the complex and multi-dimensional
networks that must be unraveled to
provide a detailed understanding of how
these proteins function in vesicular
transport.
Many Rabs and Arfs are ‘hijacked’
by pathogens
Many infectious agents reorganize
intracellular membranes to optimize
replication and/or inhibit the host
secretory pathway to prevent the release
of proinflammatory signaling molecules.
Because Rabs and Arfs control
compartment identity and regulate
trafficking pathways, many pathogens
evolved mechanisms to subvert their
function. For example, Craig Roy (Yale
University, New Haven, CT) discussed
how the intracellular bacterial pathogen
Legionella pneumophila diverts the
activity of Rab1, resulting in the
conversion of a plasma-membrane-
derived phagosome into an ER-derived
vacuole that supports bacterial
replication. In this example, the
bacterial protein DrrA recruits Rab1 to
the Legionella-containing vacuole and
activates it in a process requiring
distinct DrrA domains: a C-terminal
PtdIns(4)P-binding domain that anchors
DrrA at the membrane, a central GEF
domain that activates Rab1, and an N-
terminal nucleotidyl transferase activity
that attaches an AMP moiety onto the
switch II region of Rab1. This covalent
modification inhibits the ability of host
cell GAPs to inactivate Rab1, resulting in
its permanent activation.
The theme of Rab1 exploitation by
pathogens was extended by Neal Alto
(UT Southwestern, Dallas, USA) who
showed that the Escherichia coli protein
EspG and the Shigella flexneri protein
VirA contain a related domain with
Rab1 GAP activity that inactivates Rab1
to disrupt host protein secretion.
Additionally, EspG contains a domain
that interacts with Arf6, suggesting that
EspG can rewire both Arf6 and Rab1
signaling. Furthermore, the Shigella
protein IpaJ also targets Arfs, but by a
distinct mechanism: IpaJ is a protease that
cleaves the N-terminal glycine residue of
Arfs, which is required for myristoylation.
This irreversible modification renders
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Arfs (and possibly other myristoylated
proteins) non-functional, and blocks host
protein secretion.
Whereas Shigella inactivates Arf,
poliovirus might need Arf function to
generate viral ‘replication factories’ in
host cells. poliovirus causes the
amplification of membranous structures
that are likely to be derived from the
ER–Golgi intermediate compartment
(ERGIC) and/or the Golgi, on which
viral replication and virion assembly
occurs. George Belov (University of
Maryland, College Park, MD) showed
that viral replication itself but not the
membrane remodeling requires the Arf
GEF GBF1, and that the N-terminal
region rather than the catalytic GEF
domain is essential for viral replication.
This implies that inhibitors that target the
N-terminal region in GBF1, but do not
inhibit Arf activation might be used to
combat viral infection.
Pathogens also subvert cellular
degradative pathways, presumably to
prevent their own clearance. Kim
Orth (UT Southwestern, Dallas, TX)
described a mechanism by which
Vibrio parahaemolyticus manipulates
autophagic flux in host cells. The
bacterial protein VopQ binds to the Vo
domain of the vacuolar-type H+-ATPase
and forms a gated channel in the
lysosome membrane that mediates the
outward flux of ions, thus decreasing
intralysosomal pH. Disrupting lysosomal
homeostasis alters autophagic flux in the
cell, and disrupts the ability of the cell to
destroy the bacteria.
Defects in Rabs or their regulators
and effectors cause disease
The absolute requirement for a tightly
regulated Rab activation is underscored
by human diseases that are caused
by mutations in Rabs, their regulators
or effectors. Angela Wandinger-Ness
(University of New Mexico,
Albuquerque, NM) discussed mutants of
Rab7 that cause Charcot–Marie–Tooth
Disease type 2B. These mutations can
alter Rab7–effector interactions, or GEF-
and GAP-dependent regulation of
Rab7, and perturb endocytic trafficking.
In neurons, this interrupts nuclear
transmission of growth factor receptor
signals that are important to neuronal cell
differentiation and survival, causing
axonal loss and peripheral neuropathies.
Diabetes is another disease affected by
mutations in Rabs, owing to their roles in
regulating trafficking of the glucose
transporter type 4 (GLUT4). David
James (Garvan Institute, Sydney,
Australia) presented insights into the role
of Rab10 and the Rab GAP TBC1D4/
AS160 in GLUT4 trafficking. He also
described a new Rab10 GEF that, like
TBC1D4/AS160, is phosphorylated in
response to insulin and might also
modulate GLUT4 trafficking. Therefore,
there might be multiple inputs into the
activity of Rab10 to regulate GLUT4
trafficking.
The importance of Rab interactions
with motor proteins was discussed by
Jim Goldenring (Vanderbilt University,
Nashville, USA) who described an
inherited mutation in myosin Vb that
causes microvillus inclusion disease
(MVID), a fatal condition in which
intestinal epithelial cells fail to develop
brush borders. He showed that the
interaction of myosin Vb with Rab8a is
necessary for brush border assembly in
cultured epithelial cells and that the
inability of the disease-causing myosin
Vb mutant to bind to Rab8a contributes to
MVID.
Arfs and Rabs have multiple roles
in vesicle formation, lipid
dynamics, autophagy and
cytokinesis
One of the most intensively studied roles
of Arfs is in vesicle formation. It has been
proposed that activated Arfs directly
recruit coat complexes to the donor
membrane to form a vesicle, whereas
subsequent recruitment of Arf GAPs
leads to GTP hydrolysis and drives
vesicle uncoating. However, Victor Hsu
(Harvard University, Boston, MA)
reported that ArfGAP1 is present in
Golgi-derived vesicles prior to uncoating
and might act as an Arf effector that links
cargo proteins to Arfs and COPI coats
during vesicle formation. This view is
supported by the observation that ACAP1
has a similar role in clathrin coat
assembly on recycling endosomes.
On the other hand, Frank Adolf and
Felix Wieland (Heidelberg University
Biochemistry Centre, Heidelberg,
Germany) presented evidence that
ArfGAPs do not represent a component
of COPI-coated vesicles and instead
catalyze uncoating of COPI vesicles.
This group also revisited the requirement
of GTP hydrolysis for vesicle scission and
uncoating, and showed that Arf catalyzes
scission independently of GTP hydrolysis.
An important Arf function in vesicle
formation is through modifying the local
lipid environment. In budding yeast,
transport between the TGN and
endosomes requires the phospholipid
flippase Drs2, which increases membrane
curvature during vesicle formation. Todd
Graham (Vanderbilt University, Nashville,
TN) showed that Drs2 activity is enhanced
by binding to the Arf GEF Gea2 (a yeast
GBF1 ortholog); this promotes the local
accumulation of phosphatidylserine,
which in turn stimulates the recruitment
of the Arf1GAP Gcs1. Thus, Gea2 and
Drs2 act in concert to recruit coat protein
complexes and Arf effectors, and bend the
lipid bilayer.
A role of Arf in the trafficking of
glucosylceramide (GlcCer) was discussed
by Antonella DeMatteis (Telethon
Institute of Genetics and Medicine,
Naples, Italy). GlcCer is the precursor of
all glycosphingolipids and is transported
from the cis-Golgi (where it is
synthesized) to the late Golgi (where
it undergoes additional glycosylation)
through both vesicular and non-vesicular
pathways. The non-vesicular traffic is
mediated by Arf effectors, including the
four-phosphate-adaptor protein2 (FAPP2)
and Antonella DeMatteis described the
molecular mechanism through which
FAPP2 mediates directional transport of
GlcCer. She showed that without bound
GlcCer, FAPP2 targets to early Golgi
membranes, and, upon binding GlcCer,
undergoes a conformation shift that
increases its affinity for PtdIns(4)P and
promotes its targeting to the TGN where
PtdIns(4)P is enriched. There, FAPP2
releases GlcCer for its further
glycosylation.
A novel role for Arf GEFs in lipid
metabolism was described by Cathy
Jackson (CNRS, Gif-sur-Yvette, France)
who showed that GBF1 localizes to lipid
droplets (in addition to the ERGIC and
Golgi) and is required for localization
of two proteins involved in lipid
metabolism, adipose triglyceride lipase
(ATGL) and perilipin, to the droplet
surface.
A number of talks discussed the roles of
Rabs in autophagy. Juan Wang (UCSD,
San Diego, CA) reported that TRAPPIII, a
specific form of the yeast Ypt1 GEF
TRAPP, is required for early stages of
autophagy in yeast; it is recruited to
the preautophagosomal structure (PAS)
by Atg17, a scaffolding protein that
coordinates the formation of the
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autophagy initiator complex. Activated
Ypt1, in turn, recruits the kinase Atg1,
which is required for phagophore
formation, and that also interacts with
Atg17. Thus, the local activation of Ypt1
by TRAPPIII ensures that Atg1 is
recruited selectively to the PAS, rather
than to other compartments where Ypt1 is
also activated. These findings also
showcase the ability of Ypt1 to regulate
both the secretory and autophagic
pathways. Mark McNiven (Mayo Clinic,
Rochester, MN) showed that the large
GTPase dynamin (Dyn2) is required for
lipid droplet metabolism by mediating
the formation of nascent lysosome
budding from autophagolysosomes.
Under starvation conditions, lipid-loaded
hepatocytes in which Dyn2 function has
been perturbed display long tubular
LAMP1- or LC3-positive compartments
than cannot contribute to autophagic-
based lipophagy. These findings imply
that there is a new cellular location and
function for this large mechano-GTPase.
Sharon Tooze (LRI, London, UK)
described results from a screen for
RabGAPs that function in autophagy, in
which 11 of the 38 known GAPs inhibited
some aspect of autophagy. One of these,
TBC1D14, interacts with Ulk1 (the
mammalian ortholog of yeast Atg1) and
binds to Rab11. Thus, Rab11, which
normally regulates endosomal recycling,
is required for phagophore formation,
further supporting the notion of single
Rabs regulating multiple pathways.
The concept of Rab11 ‘multi-tasking’
was further developed by Rytis Prekeris
(University of Colorado, Denver, CO)
and Kazuhisa Nakayama (Kyoto
University, Kyoto, Japan) who discussed
the FIP family of Rab11 effectors. Both
showed that Rab11 and FIP3 deliver
recycling endosomes to the intercellular
bridge during cytokinesis, presumably to
provide components needed for cleavage
furrow formation and subsequent
abscission. Rytis Prekeris also showed
that another Rab11 effector, FIP5, is
involved in the development of an
apical lumen in polarizing epithelia.
Thus, Rab11 appears to control multiple
functions including recycling traffic,
autophagy, cytokinesis and cell polarity.
Arfs and Rabs are crucial
modulators of signaling pathways
Signaling can be modified by changes in
receptor localization that are dictated by
their trafficking itinerary, which itself can
be modified by signaling inputs. The role of
Arfs in trafficking of signaling receptors
was discussed by Morag Park (McGill
University, Montreal, Canada) who
presented evidence for a direct role of the
adaptor protein GGA3 and Arf6 in the
recycling of the HGF receptor Met.
She showed that GGA3/Arf6-mediated
recycling of Met maintains the high levels
of ERK activation and mitogenic signaling
and supports cell migration, whereas in the
absence of GGA3, Met is degraded in
lysosomes, attenuating ERK activity and
inhibiting HGF-mediated cell migration.
A role for Arf6 in the recycling of Met
in the context of tumor development and
metastasis was discussed by Crislyn
D’Souza-Schorey (University of Notre
Dame, Notre Dame, IN). She showed
that in 3D cell models of epithelial cysts,
Arf6 hyperactivation downstream of
extracellular agonists, such as canonical
Wnts, prevents Met recycling, and keeps
it within ‘signaling’ endosomes. This
causes sustained ERK signaling and
results in the formation of cysts with
multiple lumens instead of normal cysts
with a single lumen.
Arf GEFs also influence signaling as
discussed by Jim Casanova (University of
Virginia, Charlottesville, VA) who
described a subfamily of Arf GEFs,
BRAG1–BRAG3, that localize to
postsynaptic densities in the brain where
they modulate the trafficking of
neurotransmitter receptors to regulate
signaling at the synapse. Mutations in the
catalytic domain of BRAG1 or its
calmodulin-binding IQ-like domain have
been implicated in familial X-linked
mental disability, and corresponding
mutations were shown to either inhibit
AMPA receptor trafficking or uncouple
it from Ca2+-calmodulin signaling in
hippocampal neurons.
The role of Rabs in regulating signaling
was also discussed by Jenny Stow
(University of Queensland, Brisbane,
Australia). She showed that knockdown of
Rab8 or of phosphoinositide 3-kinase (PI3K)
in macrophages impairs the activation of Akt
and affects internalization of the Toll-like
receptor TLR4 after stimulation by bacterial
lipopolysaccharides. Such altered signaling
enhances the production of pro-
inflammatory cytokines (e.g. TNFa) and
reduces anti-inflammatory cytokines (IL-
10). The emergence of Rabs as regulators
of inflammation elicited considerable
discussion.
Conclusions and perspectives
The conference concluded with an open
discussion on the outstanding questions in
the field; the key issues for future
exploration were coincidence detection
specificity, regulation of the regulators
(e.g. GEFs and GAPs), and the interplay
between lipid and protein signaling.
Among the practical issues was the need
for close collaboration between laboratories
to integrate individually generated
information into a cohesive network of
understanding. Additionally, there is a
strong need to share reagents (plasmids,
antibodies, cell lines, expression patterns,
etc.) to optimize resources and speed of
discovery. Much remains to be done in
exploring the role of Rabs and Arfs in cell
function, and future discussions are planned
to define best means of organizing this
community to ensure rapid progress.
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